US 11952362
Compositions and methods for treating epigenetic disease
granted A61KA61K31/40A61K31/4025
Quick answer
US patent 11952362 (Compositions and methods for treating epigenetic disease) held by The Regents of the University of California expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/40, A61K31/4025, A61K31/4439, A61K31/497